We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+15.74%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$45.9M
AUM Growth
+$3.85M
Cap. Flow
-$689K
Cap. Flow %
-1.5%
Top 10 Hldgs %
19.46%
Holding
843
New
156
Increased
138
Reduced
151
Closed
116

Top Buys

Rank Stock Value
1
GMED icon
Globus Medical
GMED
+$350K
2
DIS icon
Walt Disney
DIS
+$321K
3
WMGI
Wright Medical Group Inc
WMGI
+$294K
4
T icon
AT&T
T
+$265K
5
ADT icon
ADT
ADT
+$263K

Top Sells

Rank Stock Value
1
CDNA icon
CareDx
CDNA
+$546K
2
AKTS
Akoustis Technologies Inc
AKTS
+$473K
3
VZ icon
Verizon
VZ
+$307K
4
VICR icon
Vicor
VICR
+$282K
5
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$265K

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Healthcare 13.98%
3 Financials 8.19%
4 Industrials 8.17%
5 Consumer Discretionary 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TROX icon
551
Tronox
TROX
$995M
$6K 0.01%
500
– –
TRUE
552
DELISTED
TrueCar
TRUE
$6K 0.01%
+400
New +$4.9K
UPS icon
553
United Parcel Service
UPS
$97.6B
$6K 0.01%
50
– –
YEXT icon
554
Yext
YEXT
$501M
$6K 0.01%
+250
New +$5.72K
SPLK
555
DELISTED
Splunk Inc
SPLK
$6K 0.01%
+50
New +$5.54K
TA
556
DELISTED
TravelCenters of America LLC
TA
$6K 0.01%
+200
New +$4.57K
RESN
557
DELISTED
Resonant Inc.
RESN
$6K 0.01%
1,500
– –
CA
558
DELISTED
CA, Inc.
CA
$6K 0.01%
125
– –
ABEO icon
559
Abeona Therapeutics
ABEO
$345M
$5K 0.01%
15
– –
ANGO icon
560
AngioDynamics
ANGO
$562M
$5K 0.01%
250
– –
ATRA icon
561
Atara Biotherapeutics
ATRA
$71.2M
$5K 0.01%
5
– –
BCE icon
562
BCE
BCE
$19.9B
$5K 0.01%
+118
New +$4.86K
CCI icon
563
Crown Castle
CCI
$32.7B
$5K 0.01%
+44
New +$4.9K
EINC icon
564
VanEck Energy Income ETF
EINC
$102M
$5K 0.01%
83
– –
HYPD
565
Hyperion DeFi Inc
HYPD
$38M
$5K 0.01%
16
-9
-36% -$4.01K
F icon
566
Ford
F
$57.3B
$5K 0.01%
500
-750
-60% -$7.5K
FTV icon
567
Fortive
FTV
$19B
$5K 0.01%
89
– –
MKL icon
568
Markel Group
MKL
$25B
$5K 0.01%
4
– –
NTNX icon
569
Nutanix
NTNX
$14.9B
$5K 0.01%
125
-1,750
-93% -$92.4K
PPL
570
PPL Corp
PPL
$27.3B
$5K 0.01%
+171
New +$5K
QNST icon
571
QuinStreet
QNST
$870M
$5K 0.01%
+375
New +$5.31K
SCHE icon
572
Schwab Emerging Markets Equity ETF
SCHE
$12.3B
$5K 0.01%
+185
New +$4.79K
SCHF icon
573
Schwab International Equity ETF
SCHF
$65.6B
$5K 0.01%
+300
New +$4.99K
SOHO
574
DELISTED
Sotherly Hotels
SOHO
$5K 0.01%
750
– –
TBT icon
575
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$293M
$5K 0.01%
125
– –
21 22
23
24 25

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q3 2018 Portfolio in Review

As of Q3 2018, Thompson Davis & Co held 843 positions worth $45.9M, up 9.2% from $42M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Thompson Davis & Co's Q3 2018 filing shows 156 new, 138 increased, 151 reduced and 116 closed positions. Its largest new stake was Globus Medical: 6,660 shares worth $378K. The largest sale was CareDx, an estimated $546K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Thompson Davis & Co's largest Q3 2018 buy was Globus Medical: 6,660 shares worth $378K.
  • Thompson Davis & Co added most to Walt Disney in Q3 2018, an estimated $321K increase.
  • Thompson Davis & Co's biggest Q3 2018 reduction was CareDx, cutting an estimated $546K.
  • Thompson Davis & Co fully exited Vicor in Q3 2018, selling an estimated $282K.
  • Thompson Davis & Co's ten largest holdings make up 19% of its $45.9M portfolio in Q3 2018.
  • Thompson Davis & Co opened 156 new positions and closed 116 in Q3 2018.
  • Thompson Davis & Co's portfolio value rose 9.2% quarter-over-quarter to $45.9M.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.